Chronic thromboembolic pulmonary hypertension: Animal models

European Respiratory Journal

Volumn 41, Issue 5, 2013, Pages 1200-1206

  Mercier, Olaf ^a   Fadel, Elie ^a  

^a CENTRE CHIRURGICAL MARIE LANNELONGUE   (France)

Author keywords

Chronic thromboembolic pulmonary hypertension; Pulmonary circulation; Remodelling; Right ventricular function

Indexed keywords

CELL PROTEIN; ET 1 PROTEIN; UNCLASSIFIED DRUG;

ARTERY LESION; ARTERY LIGATION; ARTICLE; BLOOD FLOW; CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION; CLINICAL FEATURE; DISEASE ACTIVITY; DISEASE ASSOCIATION; EXPERIMENTAL MODEL; EXTRAVASCULAR SPACE; FLOW RATE; HUMAN; INTRAVASCULAR THROMBOSIS; LUNG VASCULAR RESISTANCE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SYNTHESIS; PULMONARY ARTERY OCCLUSION; RISK ASSESSMENT; RISK FACTOR; THROMBOSIS; VASCULAR LESION;

CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION; PULMONARY CIRCULATION; REMODELLING; RIGHT VENTRICULAR FUNCTION;

ANGIOGRAPHY; ANIMALS; DISEASE MODELS, ANIMAL; DOGS; HUMANS; HYPERTENSION, PULMONARY; MICE; PULMONARY EMBOLISM; RATS; SWINE; THROMBOEMBOLISM; THROMBOSIS; VENTRICULAR DYSFUNCTION, RIGHT;

EID: 84877097386     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00101612     Document Type: Article

References (53)

1. Simonneau G, Robbins IM, Beghetti M, et al. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol 2009; 54: Suppl. 1, S43-S54.
2. Dartevelle P, Fadel E, Mussot S, et al. Chronic thromboembolic pulmonary hypertension. Eur Respir J 2004; 23: 637-648. (Pubitemid 38456010)
3. Hoeper MM, Mayer E, Simonneau G, et al. Chronic thromboembolic pulmonary hypertension. Circulation 2006; 113: 2011-2020.
4. Moser KM, Bloor CM. Pulmonary vascular lesions occurring in patients with chronic major vessel thromboembolic pulmonary hypertension. Chest 1993; 103: 685-692. (Pubitemid 23086157)
5. Modarai B, Humphries J, Burnand KG, et al. Adenovirus-mediated VEGF gene therapy enhances venous thrombus recanalization and resolution. Arterioscler Thromb Vasc Biol 2008; 28: 1753-1759.
6. Waltham M, Burnand K, Fenske C, et al. Vascular endothelial growth factor naked DNA gene transfer enhances thrombus recanalization and resolution. J Vasc Surg 2005; 42: 1183-1189. (Pubitemid 41817176)
7. Modarai B, Burnand KG, Humphries J, et al. The role of neovascularisation in the resolution of venous thrombus. Thromb Haemost 2005; 93: 801-809. (Pubitemid 40691533)
8. Waltham M, Burnand KG, Collins M, et al. Vascular endothelial growth factor enhances venous thrombus recanalisation and organisation. Thromb Haemost 2003; 89: 169-176. (Pubitemid 36149806)
9. McGuinness CL, Humphries J, Waltham M, et al. Recruitment of labelled monocytes by experimental venous thrombi. Thromb Haemost 2001; 85: 1018-1024. (Pubitemid 32573753)
10. Waltham M, Burnand KG, Collins M, et al. Vascular endothelial growth factor and basic fibroblast growth factor are found in resolving venous thrombi. J Vasc Surg 2000; 32: 988-996.
11. Humphries J, McGuinness CL, Smith A, et al. Monocyte chemotactic protein-1 (MCP-1) accelerates the organization and resolution of venous thrombi. J Vasc Surg 1999; 30: 894-899.
12. Singh I, Burnand KG, Collins M, et al. Failure of thrombus to resolve in urokinase-type plasminogen activator gene-knockout mice: rescue by normal bone marrow-derived cells. Circulation 2003; 107: 869-875. (Pubitemid 36241046)
13. Kang C, Bonneau M, Brouland JP, et al. In vivo pig models of venous thrombosis mimicking human disease. Thromb Haemost 2003; 89: 256-263. (Pubitemid 36227276)
14. Londy FJ, Kadell AM, Wrobleski SK, et al. Detection of perivenous inflammation in a rat model of venous thrombosis using MRV. J Invest Surg 1999; 12: 151-156. (Pubitemid 29355639)
15. Fowlkes JB, Strieter RM, Downing LJ, et al. Ultrasound echogenicity in experimental venous thrombosis. Ultrasound Med Biol 1998; 24: 1175-1182. (Pubitemid 28498983)
16. Millet J, Vaillot M, Theveniaux J, et al. Experimental venous thrombosis induced by homologous serum in the rat. Thromb Res 1996; 81: 497-502. (Pubitemid 26100417)
17. Wakefield TW, Linn MJ, Henke PK, et al. Neovascularization during venous thrombosis organization: a preliminary study. J Vasc Surg 1999; 30: 885-892.
18. Henke PK, Wakefield TW, Kadell AM, et al. Interleukin-8 administration enhances venous thrombosis resolution in a rat model. J Surg Res 2001; 99: 84-91. (Pubitemid 32613963)
19. Varma MR, Varga AJ, Knipp BS, et al. Neutropenia impairs venous thrombosis resolution in the rat. J Vasc Surg 2003; 38: 1090-1098. (Pubitemid 37409647)
20. Henke PK, Varga A, De S, et al. Deep vein thrombosis resolution is modulated by monocyte CXCR2-mediated activity in a mouse model. Arterioscler Thromb Vasc Biol 2004; 24: 1130-1137. (Pubitemid 38737842)
21. Xie H, Kim K, Aglyamov SR, et al. Staging deep venous thrombosis using ultrasound elasticity imaging: animal model. Ultrasound Med Biol 2004; 30: 1385-1396. (Pubitemid 39576191)
22. Wakefield TW, Strieter RM, Wilke CA, et al. Venous thrombosis-associated inflammation and attenuation with neutralizing antibodies to cytokines and adhesion molecules. Arterioscler Thromb Vasc Biol 1995; 15: 258-268.
23. Bonderman D, Jakowitsch J, Redwan B, et al. Role for staphylococci in misguided thrombus resolution of chronic thromboembolic pulmonary hypertension. Arterioscler Thromb Vasc Biol 2008; 28: 678-684. (Pubitemid 351651329)
24. Fadel E, Riou JY, Mazmanian M, et al. Pulmonary thromboendarterectomy for chronic thromboembolic obstruction of the pulmonary artery in piglets. J Thorac Cardiovasc Surg 1999; 117: 787-793. (Pubitemid 29163084)
25. Fadel E, Michel RP, Eddahibi S, et al. Regression of postobstructive vasculopathy after revascularization of chronically obstructed pulmonary artery. J Thorac Cardiovasc Surg 2004; 127: 1009-1017. (Pubitemid 38451933)
26. Mitzner W, Wagner EM. Vascular remodeling in the circulations of the lung. J Appl Physiol 2004; 97: 1999-2004. (Pubitemid 39426022)
27. Wagner EM, Jenkins J, Perino MG, et al. Lung and vascular function during chronic severe pulmonary ischemia. J Appl Physiol 2011; 110: 538-544.
28. Charan NB, Carvalho P. Angiogenesis in bronchial circulatory system after unilateral pulmonary artery obstruction. J Appl Physiol 1997; 82: 284-291. (Pubitemid 27052073)
29. Fadel E, Mazmanian GM, Chapelier A, et al. Lung reperfusion injury after chronic or acute unilateral pulmonary artery occlusion. Am J Respir Crit Care Med 1998; 157: 1294-1300.
30. Fadel E, Mazmanian GM, Baudet B, et al. Endothelial nitric oxide synthase function in pig lung after chronic pulmonary artery obstruction. Am J Respir Crit Care Med 2000; 162: 1429-1434.
31. Shi W, Hu F, Kassouf W, et al. Altered reactivity of pulmonary vessels in postobstructive pulmonary vasculopathy. J Appl Physiol 2000; 88: 17-25. (Pubitemid 30053822)
32. Shi W, Giaid A, Hu F, et al. Increased reactivity to endothelin of pulmonary arteries in long-term post-obstructive pulmonary vasculopathy in rats. Pulm Pharmacol Ther 1998; 11: 189-196. (Pubitemid 29041580)
33. Michel RP, Hakim TS. Increased resistance in postobstructive pulmonary vasculopathy: structure-function relationships. J Appl Physiol 1991; 71: 601-610.
34. Fadel E, Wijtenburg E, Michel R, et al. Regression of the systemic vasculature to the lung after removal of pulmonary artery obstruction. Am J Respir Crit Care Med 2006; 173: 345-349. (Pubitemid 43209090)
35. Sage E, Mercier O, Van den Eyden F, et al. Endothelial cell apoptosis in chronically obstructed and reperfused pulmonary artery. Respir Res 2008; 9: 19.
36. Mercier O, Sage E, de Perrot M, et al. Regression of flow-induced pulmonary arterial vasculopathy after flow correction in piglets. J Thorac Cardiovasc Surg 2009; 137: 1538-1546.
37. Rendas A, Lennox S, Reid L. Aorta-pulmonary shunts in growing pigs. Functional and structural assessment of the changes in the pulmonary circulation. J Thorac Cardiovasc Surg 1979; 77: 109-18. (Pubitemid 9103560)
38. Rondelet B, Kerbaul F, Motte S, et al. Bosentan for the prevention of overcirculation-induced experimental pulmonary arterial hypertension. Circulation 2003; 107: 1329-1335. (Pubitemid 36314419)
39. Reddy VM, Wong J, Liddicoat JR, et al. Altered endothelium-dependent responses in lambs with pulmonary hypertension and increased pulmonary blood flow. Am J Physiol 1996; 271: H562-H570.
40. Ovadia B, Reinhartz O, Fitzgerald R, et al. Alterations in ET-1, not nitric oxide, in 1-week-old lambs with increased pulmonary blood flow. Am J Physiol Heart Circ Physiol 2003; 284: H480-H490. (Pubitemid 36142874)
41. Mercier O, Tivane A, Raoux F, et al. A reliable piglet model of chronic thrombo-embolic pulmonary hypertension. Am J Respir Crit Care Med 2011; 183: A2415.
42. Egermayer P, Peacock AJ. Is pulmonary embolism a common cause of chronic pulmonary hypertension? Limitations of the embolic hypothesis. Eur Respir J 2000; 15: 440-448. (Pubitemid 30158178)
43. Lang I. Advances in understanding the pathogenesis of chronic thromboembolic pulmonary hypertension. Br J Haematol 2010; 149: 478-483.
44. Bonderman D, Wilkens H, Wakounig S, et al. Risk factors for chronic thromboembolic pulmonary hypertension. Eur Respir J 2009; 33: 325-331.
45. Bonderman D, Jakowitsch J, Adlbrecht C, et al. Medical conditions increasing the risk of chronic thromboembolic pulmonary hypertension. Thromb Haemost 2005; 93: 512-516. (Pubitemid 40392541)
46. Azarian R, Wartski M, Collignon MA, et al. Lung perfusion scans and hemodynamics in acute and chronic pulmonary embolism. J Nucl Med 1997; 38: 980-983. (Pubitemid 27251998)
47. Galié N, Manes A, Branzi A. The endothelin system in pulmonary arterial hypertension. Cardiovasc Res 2004; 61: 227-237. (Pubitemid 38091763)
48. Moser KM, Guisan M, Bartimmo EE, et al. In vivo and post mortem dissolution rates of pulmonary emboli and venous thrombi in the dog. Circulation 1973; 48: 170-178.
49. Moser KM, Cantor JP, Olman M, et al. Chronic pulmonary thromboembolism in dogs treated with tranexamic acid. Circulation 1991; 83: 1371-1379.
50. Marsh JJ, Konopka RG, Lang IM, et al. Suppression of thrombolysis in a canine model of pulmonary embolism. Circulation 1994; 90: 3091-3097.
51. Kim H, Yung GL, Marsh JJ, et al. Endothelin mediates pulmonary vascular remodelling in a canine model of chronic embolic pulmonary hypertension. Eur Respir J 2000; 15: 640-648. (Pubitemid 30196289)
52. Sato H, Hall CM, Griffith GW, et al. Large animal model of chronic pulmonary hypertension. ASAIO J 2008; 54: 396-400.
53. Lang IM, Marsh JJ, Konopka RG, et al. Factors contributing to increased vascular fibrinolytic activity in mongrel dogs. Circulation 1993; 87: 1990-2000. (Pubitemid 23165644)